Construct: ORF TRCN0000471916

Construct Description:

Construct Type:
ORF
Other Identifiers:
ORF013395.1_s317c1
Derived from:
ccsbBroadEn_11604
DNA Barcode:
TGTCACCTTGGTTTGGGTTGGTTC
Epitope Tag:
V5
Notes:
No stop codon in insert

Originally Annotated References:

Gene:
RABL2B (11158)

Vector Information:

Vector Backbone:
pLX_317
Pol II Cassette 1:
SV40-PuroR
Pol II Cassette 2:
EF1a-TRCN0000471916
Selection Marker:
PuroR
Visible Reporter:
n/a
Epitope Tag:
V5

Current transcripts matched by this ORF:

Taxon Gene Symbol Description Transcript Nuc. Match %[?] Prot. Match %[?] Match Diffs[?]
1 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028559.2 85.3% 85.3% 298_348del
2 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003234.1 59.1% 45% (many diffs)
3 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354424.2 52.6% 43.6% (many diffs)
4 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306161.2 52.1% 43.3% (many diffs)
5 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354421.2 52.1% 43.3% (many diffs)
6 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354423.2 52.1% 43.3% (many diffs)
7 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003226.1 52.1% 43.3% (many diffs)
8 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354418.2 51.5% 40.9% (many diffs)
9 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354419.2 51.5% 40.9% (many diffs)
10 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003223.1 51.5% 40.9% (many diffs)
11 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354417.2 43.7% 43.7% (many diffs)
12 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130922.3 43.4% 43.4% 298_684del
13 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350005.2 43.4% 43.4% 298_684del
14 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350006.2 43.4% 43.4% 298_684del
15 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350007.2 43.4% 43.4% 298_684del
16 human 11158 RABL2B RAB, member of RAS oncogene... NM_007081.4 43.4% 43.4% 298_684del
17 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028556.1 43.4% 43.4% 298_684del
18 human 11158 RABL2B RAB, member of RAS oncogene... NM_001003789.3 43.2% 43.2% 298_687del
19 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130919.3 43.2% 43.2% 298_687del
20 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130920.3 43.2% 43.2% 298_687del
21 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130921.3 43.2% 43.2% 298_687del
22 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350003.2 43.2% 43.2% 298_687del
23 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350004.2 43.2% 43.2% 298_687del
24 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028552.1 43.2% 43.2% 298_687del
25 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028555.1 43.2% 43.2% 298_687del
26 human 11158 RABL2B RAB, member of RAS oncogene... XM_024452147.1 43.2% 43.2% 298_687del
27 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354416.2 42.9% 42.9% (many diffs)
28 human 11159 RABL2A RAB, member of RAS oncogene... NM_007082.5 42.9% 42.9% (many diffs)
29 human 11159 RABL2A RAB, member of RAS oncogene... NM_013412.4 42.9% 42.9% (many diffs)
30 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003220.1 42.9% 42.9% (many diffs)
31 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003222.1 42.9% 42.9% (many diffs)
32 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306158.2 42.7% 42.7% (many diffs)
33 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306159.2 42.7% 42.7% (many diffs)
34 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354412.2 42.7% 42.7% (many diffs)
35 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354413.2 42.7% 42.7% (many diffs)
36 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354414.2 42.7% 42.7% (many diffs)
37 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003213.1 42.7% 42.7% (many diffs)
38 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003214.1 42.7% 42.7% (many diffs)
39 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003215.1 42.7% 42.7% (many diffs)
40 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003216.1 42.7% 42.7% (many diffs)
41 human 11159 RABL2A RAB, member of RAS oncogene... XM_024452575.1 42.7% 42.7% (many diffs)
42 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028551.1 42.3% 42.3% 298_702del
43 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350016.2 42.1% 42.1% 298_705del
44 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350017.2 42.1% 42.1% 298_705del
45 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003212.1 41.8% 41.8% (many diffs)
46 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003210.1 41.7% 41.7% (many diffs)
47 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003211.1 41.7% 41.7% (many diffs)
48 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130923.3 41.5% 41.5% 298_714del
49 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350013.2 41.5% 41.5% 298_714del
50 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350014.2 41.5% 41.5% 298_714del
51 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350015.2 41.5% 41.5% 298_714del
52 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028547.1 41.5% 41.5% 298_714del
53 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350008.2 41.4% 41.4% 298_717del
54 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350009.2 41.4% 41.4% 298_717del
55 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350010.2 41.4% 41.4% 298_717del
56 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350011.2 41.4% 41.4% 298_717del
57 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350012.2 41.4% 41.4% 298_717del
58 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028543.1 41.4% 41.4% 298_717del
59 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028544.1 41.4% 41.4% 298_717del
60 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028546.1 41.4% 41.4% 298_717del
61 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306160.3 41.1% 41.1% (many diffs)
62 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354410.2 41.1% 41.1% (many diffs)
63 human 11159 RABL2A RAB, member of RAS oncogene... XM_024452573.1 41.1% 41.1% (many diffs)
64 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354405.2 41% 41% (many diffs)
65 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354406.2 41% 41% (many diffs)
66 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354407.2 41% 41% (many diffs)
67 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354408.2 41% 41% (many diffs)
68 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354409.2 41% 41% (many diffs)
69 human 11159 RABL2A RAB, member of RAS oncogene... XM_006712208.3 41% 41% (many diffs)
70 human 11159 RABL2A RAB, member of RAS oncogene... XM_006712209.3 41% 41% (many diffs)
71 human 11159 RABL2A RAB, member of RAS oncogene... XM_011510509.2 41% 41% (many diffs)
72 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003203.1 41% 41% (many diffs)
73 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003204.1 41% 41% (many diffs)
74 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003205.1 41% 41% (many diffs)
75 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003207.1 41% 41% (many diffs)
76 human 11159 RABL2A RAB, member of RAS oncogene... NR_148879.2 14.5% (many diffs)
77 human 11159 RABL2A RAB, member of RAS oncogene... NR_148882.2 14.4% (many diffs)
78 human 11159 RABL2A RAB, member of RAS oncogene... NR_148881.2 14.4% (many diffs)
79 human 11159 RABL2A RAB, member of RAS oncogene... NR_148880.2 13.3% (many diffs)
80 human 11159 RABL2A RAB, member of RAS oncogene... XR_002959036.1 11.7% (many diffs)
81 mouse 68708 Rabl2 RAB, member RAS oncogene fa... XM_006521326.3 38.4% 39.1% (many diffs)
82 mouse 68708 Rabl2 RAB, member RAS oncogene fa... NM_026817.3 38.2% 39% (many diffs)
83 mouse 68708 Rabl2 RAB, member RAS oncogene fa... XM_006521327.3 25.1% 27.3% (many diffs)
Download CSV

Sequence Information

Note: uppercase bases indicate empirically verified sequence.

ORF start:
157
ORF end:
454
ORF length:
297
Sequence:
1GGCACTTGAT GTAATTCTCC TTGGAATTTG CCCTTTTTGA GTTTGGATCT TGGTTCATTC
61TCAAGCCTCA GACAGTGGTT CAAAGTTTTT TTCTTCCATT TCAGGTGTCG TGAGGCTAGC
121ATCGATTGAT CAACAAGTTT GTACAAAAAA GTTGGCATGG CAGAAGACAA AACCAAACCG
181AGTGAGTTGG ACCAAGGGAA GTATGATGCT GATGACAACG TGAAGATCAT CTGCCTGGGA
241GACAGCGCAG TGGGCAAATC CAAACTCATG GAGAGATTTC TCATGGATGG CTTTCAGCCA
301CAGCAGCTGT CCACGTACGC CCTGACCCTG TACAAGCACA CAGCCACGGT AGATGGAAGG
361ACCATCCTTG TGGACTTTTG GGACACGGCA GGCCAGGAGC GGTTCCAGAG CATGCATGCC
421TCCTACTACC ACAAGGCCCA CGCCTGCATC ATGTGCCCAA CTTTCTTGTA CAAAGTGGTT
481GATATCGGTA AGCCTATCCC TAACCCTCTC CTCGGTCTCG ATTCTACGTA GTAATGAACT
541AGTCCGTAAC TTGAAAGTAT TTCGATTTCT TGGCTTTATA TATCTTGTGG AAAGGACGAT
601GTCACCTTGG TTTGGGTTGG TTCACGCGTT AAGTCgacaa tcaacctctg gattacaaaa
661tttgtgaaag att

Download FASTA (ORF) (Full)